EHMT2 and esophageal squamous cell carcinoma: Given the potent, synergistic effect of inhibiting both LSD1 and G9a on the viability of cultured ESCC cells in vitro, we next tested whether pharmacologically inhibiting these two enzymes affects the in vivo viability of xenografted Kyse510 and Kyse30 ESCCs.